The global Dermal Filler and Botolinum Toxin market size is expected to reach US$ 30390 million by 2029, growing at a CAGR of 13.9% from 2023 to 2029.

Dermal Filler and Botolinum Toxin - Market

This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.

The market is mainly driven by the significant applications of Dermal Filler and Botolinum Toxin in various end use industries. The expanding demands from the Aesthetic Restoration and Wrinkle Reduction, are propelling Dermal Filler and Botolinum Toxin market. Hyaluronic Acid Based Fillers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Hyaluronic Acid Based Fillers segment is estimated at % CAGR for the next seven-year period.

Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dermal Filler and Botolinum Toxin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Dermal Filler and Botolinum Toxin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Dermal Filler and Botolinum Toxin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dermal Filler and Botolinum Toxin sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Dermal Filler and Botolinum Toxin covered in this report include Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Suneva Medical, Contura, HUGEL, Grex Pharma and Daewoong Pharmaceuticals, etc.

The global Dermal Filler and Botolinum Toxin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Allergan

Galderma

Merz Pharma GmbH & Co. KGaA

Anika Therapeutics

Suneva Medical

Contura

HUGEL

Grex Pharma

Daewoong Pharmaceuticals

Medy-Tox

TEOXANE Laboratories

SciVision Biotech

Scope of Dermal Filler and Botolinum Toxin - Market Report

Report Metric	Details
Report Name	Dermal Filler and Botolinum Toxin - Market
Forecasted market size in 2029	US$ 30390 million
CAGR	13.9%
Forecasted years	2023 - 2029
Global Dermal Filler and Botolinum Toxin market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dermal Filler and Botolinum Toxin market, Segment by Type:	Hyaluronic Acid Based Fillers Non-Hyaluronic Acid Based Fillers Botulinum Toxin
Global Dermal Filler and Botolinum Toxin market, by Application	Aesthetic Restoration Wrinkle Reduction
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dermal Filler and Botolinum Toxin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dermal Filler and Botolinum Toxin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Dermal Filler and Botolinum Toxin - Market size in 2029?

Ans: The Dermal Filler and Botolinum Toxin - Market size in 2029 will be US$ 30390 million.

What are the Application segmentation covered in the Dermal Filler and Botolinum Toxin - Market report?

Ans: The Applications covered in the Dermal Filler and Botolinum Toxin - Market report are Aesthetic Restoration, Wrinkle Reduction

What are the Type segmentation covered in the Dermal Filler and Botolinum Toxin - Market report?

Ans: The Types covered in the Dermal Filler and Botolinum Toxin - Market report are Hyaluronic Acid Based Fillers, Non-Hyaluronic Acid Based Fillers, Botulinum Toxin

1 Dermal Filler and Botolinum Toxin Market Overview

1.1 Dermal Filler and Botolinum Toxin Product Overview

1.2 Dermal Filler and Botolinum Toxin Market Segment by Type

1.2.1 Hyaluronic Acid Based Fillers

1.2.2 Non-Hyaluronic Acid Based Fillers

1.2.3 Botulinum Toxin

1.3 Global Dermal Filler and Botolinum Toxin Market Size by Type

1.3.1 Global Dermal Filler and Botolinum Toxin Market Size Overview by Type (2018-2029)

1.3.2 Global Dermal Filler and Botolinum Toxin Historic Market Size Review by Type (2018-2023)

1.3.3 Global Dermal Filler and Botolinum Toxin Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Dermal Filler and Botolinum Toxin Sales Breakdown by Type (2018-2023)

1.4.2 Europe Dermal Filler and Botolinum Toxin Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Dermal Filler and Botolinum Toxin Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Dermal Filler and Botolinum Toxin Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Dermal Filler and Botolinum Toxin Sales Breakdown by Type (2018-2023)

2 Global Dermal Filler and Botolinum Toxin Market Competition by Company

2.1 Global Top Players by Dermal Filler and Botolinum Toxin Sales (2018-2023)

2.2 Global Top Players by Dermal Filler and Botolinum Toxin Revenue (2018-2023)

2.3 Global Top Players by Dermal Filler and Botolinum Toxin Price (2018-2023)

2.4 Global Top Manufacturers Dermal Filler and Botolinum Toxin Manufacturing Base Distribution, Sales Area, Product Type

2.5 Dermal Filler and Botolinum Toxin Market Competitive Situation and Trends

2.5.1 Dermal Filler and Botolinum Toxin Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Dermal Filler and Botolinum Toxin Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermal Filler and Botolinum Toxin as of 2022)

2.7 Date of Key Manufacturers Enter into Dermal Filler and Botolinum Toxin Market

2.8 Key Manufacturers Dermal Filler and Botolinum Toxin Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Dermal Filler and Botolinum Toxin Status and Outlook by Region

3.1 Global Dermal Filler and Botolinum Toxin Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Dermal Filler and Botolinum Toxin Historic Market Size by Region

3.2.1 Global Dermal Filler and Botolinum Toxin Sales in Volume by Region (2018-2023)

3.2.2 Global Dermal Filler and Botolinum Toxin Sales in Value by Region (2018-2023)

3.2.3 Global Dermal Filler and Botolinum Toxin Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Dermal Filler and Botolinum Toxin Forecasted Market Size by Region

3.3.1 Global Dermal Filler and Botolinum Toxin Sales in Volume by Region (2024-2029)

3.3.2 Global Dermal Filler and Botolinum Toxin Sales in Value by Region (2024-2029)

3.3.3 Global Dermal Filler and Botolinum Toxin Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Dermal Filler and Botolinum Toxin by Application

4.1 Dermal Filler and Botolinum Toxin Market Segment by Application

4.1.1 Aesthetic Restoration

4.1.2 Wrinkle Reduction

4.2 Global Dermal Filler and Botolinum Toxin Market Size by Application

4.2.1 Global Dermal Filler and Botolinum Toxin Market Size Overview by Application (2018-2029)

4.2.2 Global Dermal Filler and Botolinum Toxin Historic Market Size Review by Application (2018-2023)

4.2.3 Global Dermal Filler and Botolinum Toxin Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Dermal Filler and Botolinum Toxin Sales Breakdown by Application (2018-2023)

4.3.2 Europe Dermal Filler and Botolinum Toxin Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Dermal Filler and Botolinum Toxin Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Dermal Filler and Botolinum Toxin Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Dermal Filler and Botolinum Toxin Sales Breakdown by Application (2018-2023)

5 North America Dermal Filler and Botolinum Toxin by Country

5.1 North America Dermal Filler and Botolinum Toxin Historic Market Size by Country

5.1.1 North America Dermal Filler and Botolinum Toxin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2018-2023)

5.1.3 North America Dermal Filler and Botolinum Toxin Sales in Value by Country (2018-2023)

5.2 North America Dermal Filler and Botolinum Toxin Forecasted Market Size by Country

5.2.1 North America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2024-2029)

5.2.2 North America Dermal Filler and Botolinum Toxin Sales in Value by Country (2024-2029)

6 Europe Dermal Filler and Botolinum Toxin by Country

6.1 Europe Dermal Filler and Botolinum Toxin Historic Market Size by Country

6.1.1 Europe Dermal Filler and Botolinum Toxin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Dermal Filler and Botolinum Toxin Sales in Volume by Country (2018-2023)

6.1.3 Europe Dermal Filler and Botolinum Toxin Sales in Value by Country (2018-2023)

6.2 Europe Dermal Filler and Botolinum Toxin Forecasted Market Size by Country

6.2.1 Europe Dermal Filler and Botolinum Toxin Sales in Volume by Country (2024-2029)

6.2.2 Europe Dermal Filler and Botolinum Toxin Sales in Value by Country (2024-2029)

7 Asia-Pacific Dermal Filler and Botolinum Toxin by Region

7.1 Asia-Pacific Dermal Filler and Botolinum Toxin Historic Market Size by Region

7.1.1 Asia-Pacific Dermal Filler and Botolinum Toxin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Dermal Filler and Botolinum Toxin Forecasted Market Size by Region

7.2.1 Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Dermal Filler and Botolinum Toxin Sales in Value by Region (2024-2029)

8 Latin America Dermal Filler and Botolinum Toxin by Country

8.1 Latin America Dermal Filler and Botolinum Toxin Historic Market Size by Country

8.1.1 Latin America Dermal Filler and Botolinum Toxin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2018-2023)

8.1.3 Latin America Dermal Filler and Botolinum Toxin Sales in Value by Country (2018-2023)

8.2 Latin America Dermal Filler and Botolinum Toxin Forecasted Market Size by Country

8.2.1 Latin America Dermal Filler and Botolinum Toxin Sales in Volume by Country (2024-2029)

8.2.2 Latin America Dermal Filler and Botolinum Toxin Sales in Value by Country (2024-2029)

9 Middle East and Africa Dermal Filler and Botolinum Toxin by Country

9.1 Middle East and Africa Dermal Filler and Botolinum Toxin Historic Market Size by Country

9.1.1 Middle East and Africa Dermal Filler and Botolinum Toxin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Dermal Filler and Botolinum Toxin Forecasted Market Size by Country

9.2.1 Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Dermal Filler and Botolinum Toxin Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Allergan

10.1.1 Allergan Company Information

10.1.2 Allergan Introduction and Business Overview

10.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Allergan Dermal Filler and Botolinum Toxin Products Offered

10.1.5 Allergan Recent Development

10.2 Galderma

10.2.1 Galderma Company Information

10.2.2 Galderma Introduction and Business Overview

10.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Galderma Dermal Filler and Botolinum Toxin Products Offered

10.2.5 Galderma Recent Development

10.3 Merz Pharma GmbH & Co. KGaA

10.3.1 Merz Pharma GmbH & Co. KGaA Company Information

10.3.2 Merz Pharma GmbH & Co. KGaA Introduction and Business Overview

10.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Products Offered

10.3.5 Merz Pharma GmbH & Co. KGaA Recent Development

10.4 Anika Therapeutics

10.4.1 Anika Therapeutics Company Information

10.4.2 Anika Therapeutics Introduction and Business Overview

10.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Products Offered

10.4.5 Anika Therapeutics Recent Development

10.5 Suneva Medical

10.5.1 Suneva Medical Company Information

10.5.2 Suneva Medical Introduction and Business Overview

10.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Products Offered

10.5.5 Suneva Medical Recent Development

10.6 Contura

10.6.1 Contura Company Information

10.6.2 Contura Introduction and Business Overview

10.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Contura Dermal Filler and Botolinum Toxin Products Offered

10.6.5 Contura Recent Development

10.7 HUGEL

10.7.1 HUGEL Company Information

10.7.2 HUGEL Introduction and Business Overview

10.7.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.7.4 HUGEL Dermal Filler and Botolinum Toxin Products Offered

10.7.5 HUGEL Recent Development

10.8 Grex Pharma

10.8.1 Grex Pharma Company Information

10.8.2 Grex Pharma Introduction and Business Overview

10.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Products Offered

10.8.5 Grex Pharma Recent Development

10.9 Daewoong Pharmaceuticals

10.9.1 Daewoong Pharmaceuticals Company Information

10.9.2 Daewoong Pharmaceuticals Introduction and Business Overview

10.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Products Offered

10.9.5 Daewoong Pharmaceuticals Recent Development

10.10 Medy-Tox

10.10.1 Medy-Tox Company Information

10.10.2 Medy-Tox Introduction and Business Overview

10.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Products Offered

10.10.5 Medy-Tox Recent Development

10.11 TEOXANE Laboratories

10.11.1 TEOXANE Laboratories Company Information

10.11.2 TEOXANE Laboratories Introduction and Business Overview

10.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Products Offered

10.11.5 TEOXANE Laboratories Recent Development

10.12 SciVision Biotech

10.12.1 SciVision Biotech Company Information

10.12.2 SciVision Biotech Introduction and Business Overview

10.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2018-2023)

10.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Products Offered

10.12.5 SciVision Biotech Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Dermal Filler and Botolinum Toxin Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Dermal Filler and Botolinum Toxin Industrial Chain Analysis

11.4 Dermal Filler and Botolinum Toxin Market Dynamics

11.4.1 Dermal Filler and Botolinum Toxin Industry Trends

11.4.2 Dermal Filler and Botolinum Toxin Market Drivers

11.4.3 Dermal Filler and Botolinum Toxin Market Challenges

11.4.4 Dermal Filler and Botolinum Toxin Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Dermal Filler and Botolinum Toxin Distributors

12.3 Dermal Filler and Botolinum Toxin Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Allergan plc

Galderma

Merz Pharma GmbH & Co KgaA

Daewoong Pharmaceuticals

Medy Tox

TEOXANE Laboratories

SciVision Biotech

List of Tables

Table 1. Major Company of Hyaluronic Acid Based Fillers

Table 2. Major Company of Non-Hyaluronic Acid Based Fillers

Table 3. Major Company of Botulinum Toxin

Table 4. Global Dermal Filler and Botolinum Toxin Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 5. Global Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (K MT)

Table 6. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type (2018-2023)

Table 7. Global Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US& Million)

Table 8. Global Dermal Filler and Botolinum Toxin Market Share in Value by Type (2018-2023)

Table 9. Global Dermal Filler and Botolinum Toxin Price by Type (2018-2023) & (USD/MT)

Table 10. Global Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)

Table 11. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type (2024-2029)

Table 12. Global Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (US$ Million)

Table 13. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type (2024-2029)

Table 14. Global Dermal Filler and Botolinum Toxin Price by Type (2024-2029) & (USD/MT)

Table 15. North America Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (K MT)

Table 16. North America Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US$ Million)

Table 17. Europe Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2018-2023)

Table 18. Europe Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US$ Million)

Table 19. Asia-Pacific Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2018-2023)

Table 20. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US$ Million)

Table 21. Latin America Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2018-2023)

Table 22. Latin America Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US$ Million)

Table 23. Middle East and Africa Dermal Filler and Botolinum Toxin Sales (K MT) by Type (2018-2023)

Table 24. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Type (2018-2023) & (US$ Million)

Table 25. Global Dermal Filler and Botolinum Toxin Sales by Company (2018-2023) & (K MT)

Table 26. Global Dermal Filler and Botolinum Toxin Sales Share by Company (2018-2023)

Table 27. Global Dermal Filler and Botolinum Toxin Revenue by Company (2018-2023) & (US$ Million)

Table 28. Global Dermal Filler and Botolinum Toxin Revenue Share by Company (2018-2023)

Table 29. Global Market Dermal Filler and Botolinum Toxin Price by Company (2018-2023) & (USD/MT)

Table 30. Global Dermal Filler and Botolinum Toxin Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 31. Global Dermal Filler and Botolinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermal Filler and Botolinum Toxin as of 2022)

Table 33. Date of Key Manufacturers Enter into Dermal Filler and Botolinum Toxin Market

Table 34. Key Manufacturers Dermal Filler and Botolinum Toxin Product Type

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Dermal Filler and Botolinum Toxin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 37. Global Dermal Filler and Botolinum Toxin Sales by Region (2018-2023) & (K MT)

Table 38. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Region (2018-2023)

Table 39. Global Dermal Filler and Botolinum Toxin Sales by Region (2018-2023) & (US$ Million)

Table 40. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Region (2018-2023)

Table 41. Global Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 42. Global Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (K MT)

Table 43. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Region (2024-2029)

Table 44. Global Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (US$ Million)

Table 45. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Region (2024-2029)

Table 46. Global Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)

Table 47. Global Dermal Filler and Botolinum Toxin Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 48. Global Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (K MT)

Table 49. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application (2018-2023)

Table 50. Global Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 51. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application (2018-2023)

Table 52. Global Dermal Filler and Botolinum Toxin Price by Application (2018-2023) & (USD/MT)

Table 53. Global Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)

Table 54. Global Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application (2024-2029)

Table 55. Global Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (US$ Million)

Table 56. Global Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application (2024-2029)

Table 57. Global Dermal Filler and Botolinum Toxin Price by Application (2024-2029) & (USD/MT)

Table 58. North America Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) (K MT)

Table 59. North America Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 60. Europe Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) (K MT)

Table 61. Europe Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 62. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) (K MT)

Table 63. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 64. Latin America Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) (K MT)

Table 65. Latin America Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 66. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) (K MT)

Table 67. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Application (2018-2023) & (US$ Million)

Table 68. North America Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (K MT)

Table 69. North America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2018-2023)

Table 70. North America Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (US$ Million)

Table 71. North America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2018-2023)

Table 72. North America Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)

Table 73. North America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2024-2029)

Table 74. North America Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (US$ Million)

Table 75. North America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2024-2029)

Table 76. Europe Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (K MT)

Table 77. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2018-2023)

Table 78. Europe Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (US$ Million)

Table 79. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2018-2023)

Table 80. Europe Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)

Table 81. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2024-2029)

Table 82. Europe Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (US$ Million)

Table 83. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2024-2029)

Table 84. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Region (2018-2023) & (K MT)

Table 85. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Region (2018-2023)

Table 86. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Region (2018-2023) & (US$ Million)

Table 87. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Value by Region (2018-2023)

Table 88. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (K MT)

Table 89. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Region (2024-2029)

Table 90. Asia-Pacific Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (US$ Million)

Table 91. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Value by Region (2024-2029)

Table 92. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (K MT)

Table 93. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2018-2023)

Table 94. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (US$ Million)

Table 95. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2018-2023)

Table 96. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)

Table 97. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2024-2029)

Table 98. Latin America Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (US$ Million)

Table 99. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2024-2029)

Table 100. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (K MT)

Table 101. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2018-2023)

Table 102. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2018-2023) & (US$ Million)

Table 103. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2018-2023)

Table 104. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)

Table 105. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Country (2024-2029)

Table 106. Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (US$ Million)

Table 107. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Value by Country (2024-2029)

Table 108. Allergan Company Information

Table 109. Allergan Introduction and Business Overview

Table 110. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 111. Allergan Dermal Filler and Botolinum Toxin Product

Table 112. Allergan Recent Development

Table 113. Galderma Company Information

Table 114. Galderma Introduction and Business Overview

Table 115. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 116. Galderma Dermal Filler and Botolinum Toxin Product

Table 117. Galderma Recent Development

Table 118. Merz Pharma GmbH & Co. KGaA Company Information

Table 119. Merz Pharma GmbH & Co. KGaA Introduction and Business Overview

Table 120. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 121. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product

Table 122. Merz Pharma GmbH & Co. KGaA Recent Development

Table 123. Anika Therapeutics Company Information

Table 124. Anika Therapeutics Introduction and Business Overview

Table 125. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 126. Anika Therapeutics Dermal Filler and Botolinum Toxin Product

Table 127. Anika Therapeutics Recent Development

Table 128. Suneva Medical Company Information

Table 129. Suneva Medical Introduction and Business Overview

Table 130. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 131. Suneva Medical Dermal Filler and Botolinum Toxin Product

Table 132. Suneva Medical Recent Development

Table 133. Contura Company Information

Table 134. Contura Introduction and Business Overview

Table 135. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 136. Contura Dermal Filler and Botolinum Toxin Product

Table 137. Contura Recent Development

Table 138. HUGEL Company Information

Table 139. HUGEL Introduction and Business Overview

Table 140. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 141. HUGEL Dermal Filler and Botolinum Toxin Product

Table 142. HUGEL Recent Development

Table 143. Grex Pharma Company Information

Table 144. Grex Pharma Introduction and Business Overview

Table 145. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 146. Grex Pharma Dermal Filler and Botolinum Toxin Product

Table 147. Grex Pharma Recent Development

Table 148. Daewoong Pharmaceuticals Company Information

Table 149. Daewoong Pharmaceuticals Introduction and Business Overview

Table 150. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 151. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product

Table 152. Daewoong Pharmaceuticals Recent Development

Table 153. Medy-Tox Company Information

Table 154. Medy-Tox Introduction and Business Overview

Table 155. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 156. Medy-Tox Dermal Filler and Botolinum Toxin Product

Table 157. Medy-Tox Recent Development

Table 158. TEOXANE Laboratories Company Information

Table 159. TEOXANE Laboratories Introduction and Business Overview

Table 160. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 161. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product

Table 162. TEOXANE Laboratories Recent Development

Table 163. SciVision Biotech Company Information

Table 164. SciVision Biotech Introduction and Business Overview

Table 165. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 166. SciVision Biotech Dermal Filler and Botolinum Toxin Product

Table 167. SciVision Biotech Recent Development

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. Dermal Filler and Botolinum Toxin Market Trends

Table 171. Dermal Filler and Botolinum Toxin Market Drivers

Table 172. Dermal Filler and Botolinum Toxin Market Challenges

Table 173. Dermal Filler and Botolinum Toxin Market Restraints

Table 174. Dermal Filler and Botolinum Toxin Distributors List

Table 175. Dermal Filler and Botolinum Toxin Downstream Customers

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Dermal Filler and Botolinum Toxin Product Picture

Figure 2. Global Dermal Filler and Botolinum Toxin Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Dermal Filler and Botolinum Toxin Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Dermal Filler and Botolinum Toxin Sales Status and Outlook (2018-2029) & (K MT)

Figure 5. Product Picture of Hyaluronic Acid Based Fillers

Figure 6. Global Hyaluronic Acid Based Fillers Sales YoY Growth (2018-2029) & (K MT)

Figure 7. Product Picture of Non-Hyaluronic Acid Based Fillers

Figure 8. Global Non-Hyaluronic Acid Based Fillers Sales YoY Growth (2018-2029) & (K MT)

Figure 9. Product Picture of Botulinum Toxin

Figure 10. Global Botulinum Toxin Sales YoY Growth (2018-2029) & (K MT)

Figure 11. Global Dermal Filler and Botolinum Toxin Sales by Type (2018-2029) & (US$ Million)

Figure 12. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type in 2022 & 2029

Figure 13. North America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type in 2022

Figure 14. North America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type in 2022

Figure 15. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type in 2022

Figure 16. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type in 2022

Figure 17. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type in 2022

Figure 18. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type in 2022

Figure 19. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type in 2022

Figure 20. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type in 2022

Figure 21. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Type in 2022

Figure 22. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Value by Type in 2022

Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermal Filler and Botolinum Toxin Sales in 2022

Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermal Filler and Botolinum Toxin Revenue in 2022

Figure 25. Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 26. Product Picture of Aesthetic Restoration

Figure 27. Global Aesthetic Restoration Sales YoY Growth (2018-2029) & (K MT)

Figure 28. Product Picture of Wrinkle Reduction

Figure 29. Global Wrinkle Reduction Sales YoY Growth (2018-2029) & (K MT)

Figure 30. Global Dermal Filler and Botolinum Toxin Sales by Application (2018-2029) & (US$ Million)

Figure 31. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application in 2022 & 2029

Figure 32. North America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application in 2022

Figure 33. North America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application in 2022

Figure 34. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application in 2022

Figure 35. Europe Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application in 2022

Figure 36. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application in 2022

Figure 37. Asia-Pacific Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application in 2022

Figure 38. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Volume by Application in 2022

Figure 39. Latin America Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application in 2022

Figure 40. Middle East and Africa Dermal Filler and Botolinum Toxin Sales Market Share in Value by Application in 2022

Figure 41. Key Raw Materials Price

Figure 42. Dermal Filler and Botolinum Toxin Manufacturing Cost Structure

Figure 43. Dermal Filler and Botolinum Toxin Industrial Chain Analysis

Figure 44. Channels of Distribution

Figure 45. Distributors Profiles

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Hydroxycamptothecin - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-21F13841

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Ampoules and Syringes - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-20J6982

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Urokinase - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Z9012

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

Animal Blood Plasma Products and Derivatives - Global Market Insights and Sales Trends 2024

120 Pages

Type: Report

Code: QYRE-Auto-34E6831

Fri Dec 01 00:00:00 UTC 2023

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions